MetLife (MET)
(Delayed Data from NYSE)
$71.90 USD
-0.82 (-1.13%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $71.89 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth D Momentum C VGM
Income Statements
Fiscal Year end for MetLife, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 66,905 | 69,898 | 71,080 | 67,842 | 69,620 |
Cost Of Goods | 52,078 | 55,005 | 50,368 | 47,765 | 49,136 |
Gross Profit | 14,827 | 14,893 | 20,712 | 20,077 | 20,484 |
Selling & Adminstrative & Depr. & Amort Expenses | 12,665 | 12,034 | 12,586 | 13,150 | 13,689 |
Income After Depreciation & Amortization | 2,162 | 2,859 | 8,126 | 6,927 | 6,795 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 2,162 | 2,859 | 8,126 | 6,927 | 6,795 |
Income Taxes | 560 | 301 | 1,551 | 1,509 | 886 |
Minority Interest | 24 | 19 | 21 | 11 | 10 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,602 | 2,558 | 6,575 | 5,418 | 5,909 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1,578 | 2,539 | 6,554 | 5,407 | 5,899 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,548 | 2,572 | 7,965 | 6,730 | 6,426 |
Depreciation & Amortization (Cash Flow) | -614 | -287 | -161 | -197 | -369 |
Income After Depreciation & Amortization | 2,162 | 2,859 | 8,126 | 6,927 | 6,795 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 762.30 | 808.90 | 869.40 | 913.91 | 944.40 |
Diluted EPS Before Non-Recurring Items | 7.33 | 6.85 | 9.15 | 6.16 | 6.11 |
Diluted Net EPS (GAAP) | 1.81 | 2.91 | 7.31 | 5.68 | 6.06 |
Fiscal Year end for MetLife, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 19,028.00 | 15,866.00 | 16,623.00 | 15,388.00 |
Cost Of Goods | NA | 14,774.00 | 12,145.00 | 13,076.00 | 12,083.00 |
Gross Profit | NA | 4,254.00 | 3,721.00 | 3,547.00 | 3,305.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3,313.00 | 3,187.00 | 3,117.00 | 3,048.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 941.00 | 534.00 | 430.00 | 257.00 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 941.00 | 534.00 | 430.00 | 257.00 |
Income Taxes | NA | 327.00 | 39.00 | 22.00 | 172.00 |
Minority Interest | NA | 7.00 | 6.00 | 6.00 | 5.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 614.00 | 495.00 | 408.00 | 85.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 607.00 | 489.00 | 402.00 | 80.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 743.40 | 755.50 | 769.60 | 781.20 |
Diluted EPS Before Non-Recurring Items | NA | 1.93 | 1.97 | 1.94 | 1.52 |
Diluted Net EPS (GAAP) | NA | 0.75 | 0.56 | 0.48 | 0.02 |